Funding
FDA - HHSF22301008T
Catalyst and Broader Uses of Sentinel Infrastructure
Funder: Food and Drug Administration
PI: Richard Platt, Harvard Pilgrim Health Care
Period of Performance: August 16, 2016 - December 31, 2021
Objectives
Supported Publications that Include Dr. Parlett
- Cocoros NM , Gurwitz J , Cziraky MJ et al . Pragmatic guidance for embedding pragmatic clinical trials in health plans: large simple trials aren't so simple .Clin Trials. 2023; 20 (4) : 416-24 . doi: 10.1177/17407745231160459 .
- Pokorney SD , Cocoros NM , Al-Khalidi HR et al . Effect of mailing educational material to patients with atrial fibrillation and their clinicians on use of oral anticoagulants: a randomized clinical trial .Jama Netw Open. 2022; 5 (5) : e221432 . doi: 10.1001/jamanetworkopen.2022.14321 .
- Garcia C , Haynes K , Pokorney SD et al . Practical challenges in the conduct of pragmatic trials embedded in health plans: lessons of impact-afib, an FDA-CATALYST trial .Clin Trials. 2020; 17 (4) : 360-7 . doi: 10.1177/1740774520928426 .
- Cocoros NM , Pokorney SD , Haynes K et al . Fda-catalyst-using FDA's Sentinel initiative for large-scale pragmatic randomized trials: approach and lessons learned during the planning phase of the first trial .Clin Trials. 2019; 16 (1) : 90-7 . doi: 10.1177/1740774518812776 .